Because Pfizer used the phrasing “pay no more than” $15 or $20 rather than “pay as little as” those amounts in copay cards for three of its branded products, the New York State Attorney General received complaints from consumers who […]
Read MoreIn a news release along with an updated corporate Code of Practice, GSK announced that it is returning to the practice of reimbursing healthcare providers for engaging in speaker programs, attending GSK-sponsored meetings, and paying registration fees for remote webinars […]
Read More
At the just-concluded PDA Universe of Pre-Filled Syringes meeting (Orlando, FL, Oct. 8-9), Noble, an Orlando, FL, manufacturer, demo’d a new training platform for patients using prefilled syringes based on BD syringe designs. The training units (which simulate the administration […]
Read MoreJust a month after acquiring e-benefits-verification provider VirMedica, CareMetx has made a second acquisition, the hub services provider BioSolutia. Dan Desmarais and Jim Long, principals and co-founders of BioSolutia, will take on leadership roles for CareMetx, joining Mark Hansan, CareMetX […]
Read More
One of the broad trends in hubs and related patient-support services is automation, usually in the form of text refill reminders, in-home diagnostics and the like. Now, those services are taking on a human appearance: two bots, or virtual assistants—Ella, […]
Read MoreHub services—usually funded by pharma companies to enable patients to navigate the complex administration of specialty pharmaceuticals—depend on solidly built IT platforms to manage the flow of data among patients, healthcare providers, insurers and, ultimately, manufacturers. Now, two of the […]
Read More
Hu-manity.co, a startup, is quickly following through on its initial announcements to build a personal data-ownership service, starting with the health records that are of interest to pharma and healthcare companies (who might now pay individuals for access to the […]
Read More
The FDA approval of Onpattro (patisiran) infusion, from Alnylam Pharmaceuticals, while expected, nevertheless is generating considerable buzz in pharmaceutical circles. The therapy is intended for a rare condition called hATTR (hereditary transthyretin-mediated amyloidosis); it addresses the polyneuropathy caused by the […]
Read MoreThe news is that Veeva Systems has won over three new clients—Nestle Health Science, Indivior and Syner-Med—to its OpenData service, which provides verified data on physicians and other healthcare practitioners in 42 countries globally. Veeva integrates this data source with […]
Read More
This could be construed as getting ahead of the regulatory and reimbursement practices of global healthcare systems—or keeping up with them. In either case, the Alliance for Regenerative Medicine’s Research Foundation (ARM Foundation) has issued a “landscape analysis” of current […]
Read More